What this study adds ?
The use of generic imatinib is widely prevalent throughout the globe, although its efficacy and tolerability is still debated.To the best of our knowledge this is the first trial on treatment free remission in patients on generic imatinib.
Conflict of Interest : All authors declare that there is no conflict of interest.
Ethics approval : All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethics approval was sought from the institute ethics committee
Informed consent : Informed consent was obtained from all individual participants included in the study.
Principal Investigator Statement : The authors confirm that the Principal Investigator for this paper is Deepak Goni and he had direct clinical responsibility for patients.
Author Contributions : DG and RN conducted the study,NJ did the statistical analysis,PM,DL,AK,GP and AJ planned the study and drafted the final manuscript,NV and SN provided the laboratory support.